Literature DB >> 22256850

Diagnosis and treatment of Sarcocystis neurona-induced myositis in a free-ranging California sea lion.

Daphne P Carlson-Bremer1, Frances M D Gulland, Christine K Johnson, Kathleen M Colegrove, William G Van Bonn.   

Abstract

CASE DESCRIPTION: An underweight, lethargic adult female California sea lion (Zalophus californianus) became stranded along the California shore and was captured and transported to a rehabilitation hospital for assessment and care. CLINICAL
FINDINGS: Initial physical assessment revealed the sea lion was lethargic and in poor body condition. Active myositis was diagnosed on the basis of concurrent elevations in activities of alanine aminotransferase and creatine kinase detected during serum biochemical analysis. Infection with Sarcocystis neurona was diagnosed after serologic titers increased 4-fold over a 3-week period. Diagnosis was confirmed on the basis of histopathologic findings, positive results on immunohistochemical staining, and results of quantitative PCR assay on biopsy specimens obtained from the diaphragm and muscles of the dorsal cervical region. TREATMENT AND OUTCOME: Anticoccidial treatment was instituted with ponazuril (10 mg/kg [4.5 mg/lb], PO, q 24 h) and continued for 28 days. Prednisone (0.2 mg/kg [0.09 mg/lb], PO, q 12 h) was administered for 2 days and then every 24 hours for 5 days to treat associated inflammation. At the end of treatment, the sea lion was clinically normal, alanine aminotransferase and creatine kinase values were within reference limits, and antibody titers against S neurona had decreased 6-fold. The sea lion was released approximately 3 months after becoming stranded. CLINICAL RELEVANCE: S neurona-induced myositis was diagnosed in a free-ranging California sea lion. On the basis of the successful treatment and release of this sea lion, anticoccidial treatment should be considered for marine mammals in which protozoal disease is diagnosed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22256850     DOI: 10.2460/javma.240.3.324

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  5 in total

1.  Toltrazuril does not show an effect against pigeon protozoal encephalitis.

Authors:  Kristina Maier; P Olias; A D Gruber; M Lierz
Journal:  Parasitol Res       Date:  2015-02-04       Impact factor: 2.289

Review 2.  Extended-spectrum antiprotozoal bumped kinase inhibitors: A review.

Authors:  Wesley C Van Voorhis; J Stone Doggett; Marilyn Parsons; Matthew A Hulverson; Ryan Choi; Samuel L M Arnold; Michael W Riggs; Andrew Hemphill; Daniel K Howe; Robert H Mealey; Audrey O T Lau; Ethan A Merritt; Dustin J Maly; Erkang Fan; Kayode K Ojo
Journal:  Exp Parasitol       Date:  2017-01-05       Impact factor: 2.011

Review 3.  An update on Sarcocystis neurona infections in animals and equine protozoal myeloencephalitis (EPM).

Authors:  J P Dubey; D K Howe; M Furr; W J Saville; A E Marsh; S M Reed; M E Grigg
Journal:  Vet Parasitol       Date:  2015-02-07       Impact factor: 2.738

4.  Detection and characterization of diverse coccidian protozoa shed by California sea lions.

Authors:  Yvette A Girard; Christine K Johnson; Heather M Fritz; Karen Shapiro; Andrea E Packham; Ann C Melli; Daphne Carlson-Bremer; Frances M Gulland; Daniel Rejmanek; Patricia A Conrad
Journal:  Int J Parasitol Parasites Wildl       Date:  2015-11-30       Impact factor: 2.674

5.  High-throughput screen of drug repurposing library identifies inhibitors of Sarcocystis neurona growth.

Authors:  Gregory D Bowden; Kirkwood M Land; Roberta M O'Connor; Heather M Fritz
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2018-02-16       Impact factor: 4.077

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.